(Q37874825)

English

Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH.

scientific article published on 11 May 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

based on heuristic

inferred from title

radioactive iodine therapy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H Tala

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

R Robbins

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

J A Fagin

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

S M Larson

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

R M Tuttle

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

0 references

publication date

11 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

The Journal of Clinical Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

2105-2111

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

5 January 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The evolving role of (131)I for the treatment of differentiated thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21565788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1210/JC.2011-0305

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37874825&oldid=2194011442"